サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701878

幹細胞製造市場レポート：製品別、用途別、エンドユーザー別、地域別、2025年～2033年

Stem Cell Manufacturing Market Report by Product, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 144 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
幹細胞製造市場レポート：製品別、用途別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

幹細胞製造の世界市場規模は2024年に142億米ドルに達しました。IMARC Groupは、2025年から2033年にかけての成長率（CAGR）は6.8%で、2033年には258億米ドルに達すると予測しています。幹細胞研究への投資の増加、慢性疾患罹患率の上昇、バイオテクノロジーの進歩、産学連携、厳しい規制、幹細胞治療に対する認知度の拡大などが市場成長を刺激しています。

幹細胞製造市場分析：

  • 主な市場促進要因：幹細胞研究に対するベンチャーキャピタルの投資拡大、政府の好意的な政策が幹細胞製造市場を大きく牽引しています。これは、ヘルスケアや再生医療の発展における幹細胞の可能性に対する認識の高まりを反映しています。
  • 主要市場動向：幹細胞製造市場の主要動向には、幹細胞研究と再生医療への支出増加、プロセスの自動化、業界プレイヤー間の協力関係の増加、バイオリアクター技術の急速な進歩などが含まれます。
  • 地理的動向：北米は主要なバイオテクノロジー企業や製薬企業の存在、幹細胞製造の臨床試験や商業化に向けた支援的な規制の枠組み、強固な研究開発（R&D）インフラ、同地域における再生医療治療に対する需要の高まりなど、いくつかの要因によって幹細胞製造市場をリードしています。
  • 競合情勢：幹細胞製造業界の主要市場企業には、Anterogen Co. Ltd.、Becton Dickinson and Company、Bio-Rad Laboratories Inc.、Bio-Techne Corporation、Corning Incorporated、FUJIFILM Holdings Corporation、Lonza Group AG、Merck KGaA、Sartorius AG、Takara Bio Inc.、Thermo Fisher Scientific Inc.などがあります。
  • 課題と機会：バイオテクノロジーとバイオ医薬品産業を後押しする政府のイニシアチブは、市場にとって大きなチャンスです。助成金、税制優遇措置、補助金などのイニシアチブは、研究開発を促進し、投資を誘致し、先端技術を導入し、治療法や治療法における科学的発見やイノベーションを加速することを目的としています。しかし、この市場は、製造のスケールアップに伴う技術的な限界といった大きな課題にも直面しており、これを克服するためには、各社に専門的な設備やインフラが必要となります。

幹細胞製造市場傾向：

幹細胞研究と再生医療への投資の増加

世界の幹細胞製造市場は、幹細胞研究および再生医療への多額の投資により、著しい盛り上がりを見せています。政府や民間組織は、ヘルスケアに革命をもたらす可能性を認識し、これらの分野に資源を投入しています。この原動力は、神経変性疾患や脊髄損傷など、これまで治療不可能とされてきた疾患に対する幹細胞治療の有望な見込みにあります。例えば、2023年8月にNew England Journal of Medicineに掲載された論文では、鎌状赤血球症（SCD）の治療における幹細胞遺伝子治療の可能性が期待されていることが明らかにされました。これらの投資は、最先端の研究、高度な製造技術の開発、臨床試験の拡大を支援しています。例えば、2021年9月、LifeCell International Pvt. Ltdは、OrbiMed Asia Partners IVから225カロールインドルピー（2,720万米ドル）の投資を受け、同社の技術的専門知識と幅広いネットワークをさらに活用し、不妊治療や細胞ベースの治療薬など、隣接する新たなカテゴリーに進出しました。さらに、2023年11月には、組換えタンパク質と必須試薬を専門とする米国のACROBiosystems Inc.が、幹細胞の発生と分化に重要なデルタ様リガンド4（DLL4）の可溶型であるGMグレードのDLL4タンパク質を上市しました。

慢性疾患の増加と革新的治療への需要

世界の幹細胞製造市場を推進するもう一つの重要な原動力は、慢性疾患の有病率の上昇です。糖尿病、心臓病、自己免疫疾患などの治療が増加傾向にあり、斬新で効果的な治療法が必要とされています。幹細胞治療は、損傷した組織や臓器を再生させることにより、これらの病気に対処する上で非常に有望です。例えば、2021年3月、Vertex Pharmaceuticalsは、1型糖尿病患者に対するヒト幹細胞由来治療薬VX-880のファスト・トラック指定をFDAから受けました。さらに、米国食品医薬品局（FDA）が2022年12月に発表したデータによると、米国には3,000万人以上が罹患する7,000以上の希少疾患が存在します。慢性疾患の罹患率は加齢とともに上昇しますが、幹細胞製造はこうした疾患との闘いに有望です。例えば、2021年10月に発表された世界保健機関（WHO）のファクトシートによると、2030年までに世界全体で65歳以上の高齢者が14億人になり、2050年までにその数は22億人と倍増すると予測されています。

バイオテクノロジーと細胞培養技術の進歩

バイオテクノロジーと細胞培養技術の進歩は、幹細胞製造の分野に革命をもたらしています。この原動力は幹細胞製造の効率と拡張性を高める上で極めて重要です。3D細胞培養システムやバイオリアクターのような細胞培養技術における画期的な進歩は、高品質の幹細胞をより大量に培養することを可能にします。加えて、CRISPR-Cas9のような遺伝子編集技術の革新は、幹細胞の特性を正確にコントロールし、治療の可能性をさらに広げます。これらの進歩は、製造工程を合理化するだけでなく、幹細胞を用いた治療法の安全性と品質を保証し、ヘルスケア関係者や患者に信頼感を与えています。例えば、2021年9月、幹細胞製造に特化した米国のバイオテクノロジー企業であるCellinoは、AI、機械学習、レーザー、その他のハードウェアやソフトウェアを統合したシステムにより、歩留まりを向上させ、製造コストを削減する方法を発表しました。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の幹細胞製造市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 消耗品
    • 主要セグメント
      • 培地
      • その他
  • 機器
    • 主要セグメント
      • バイオリアクター・インキュベーター
      • 細胞選別装置
      • その他
  • 幹細胞株
    • 主要セグメント
      • 造血幹細胞（HSC）
      • 間葉系幹細胞（MSC）
      • 人工多能性幹細胞（iPSC）
      • 胚性幹細胞（ESC）
      • 神経幹細胞（NSC）
      • 多能性成体前駆幹細胞

第7章 市場内訳：用途別

  • 調査アプリケーション
    • 主要セグメント
      • ライフサイエンス研究
      • 医薬品の発見と開発
  • 臨床応用
    • 主要セグメント
      • 同種幹細胞療法
      • 自家幹細胞療法
  • 細胞・組織バンキングアプリケーション

第8章 市場内訳：エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 学術機関、研究機関、委託調査機関
  • 病院・外科センター
  • 細胞・組織バンク
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Anterogen Co. Ltd.
    • Becton Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Corning Incorporated
    • FUJIFILM Holdings Corporation
    • Lonza Group AG
    • Merck KGaA
    • Sartorius AG
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Stem Cell Manufacturing Market: Major Drivers and Challenges
  • Figure 2: Global: Stem Cell Manufacturing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Stem Cell Manufacturing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Stem Cell Manufacturing Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Stem Cell Manufacturing Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Stem Cell Manufacturing Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Stem Cell Manufacturing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Stem Cell Manufacturing (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Stem Cell Manufacturing (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Stem Cell Manufacturing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Stem Cell Manufacturing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Stem Cell Manufacturing (Stem Cell Lines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Stem Cell Manufacturing (Stem Cell Lines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Stem Cell Manufacturing (Research Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Stem Cell Manufacturing (Research Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Stem Cell Manufacturing (Clinical Application) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Stem Cell Manufacturing (Clinical Application) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Stem Cell Manufacturing (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Stem Cell Manufacturing (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Stem Cell Manufacturing Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Stem Cell Manufacturing Industry: SWOT Analysis
  • Figure 80: Global: Stem Cell Manufacturing Industry: Value Chain Analysis
  • Figure 81: Global: Stem Cell Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Stem Cell Manufacturing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Stem Cell Manufacturing Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Stem Cell Manufacturing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Stem Cell Manufacturing Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Stem Cell Manufacturing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Stem Cell Manufacturing Market: Competitive Structure
  • Table 7: Global: Stem Cell Manufacturing Market: Key Players
目次
Product Code: SR112025A6072

The global stem cell manufacturing market size reached USD 14.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.8 Billion by 2033, exhibiting a growth rate (CAGR) of 6.8% during 2025-2033. Increasing investments in stem cell research, rising chronic disease prevalence, advancements in biotechnology, collaborations between academia and industry, stringent regulations, and expanding awareness of stem cell therapies are stimulating the market growth.

Stem Cell Manufacturing Market Analysis:

  • Major Market Drivers: Growing venture capital investment in stem cell research, supported by favorable government initiatives are majorly driving the stem cell manufacturing market. This, in turn, reflects the increasing recognition of stem cell's potential in advancing healthcare and regenerative medicine.
  • Key Market Trends: Some of the key trends in the stem cell manufacturing market include rising expenditure on stem cell research and regenerative medicine, automation of processes, increasing collaborations among industry players, and rapid advancements in bioreactor technology.
  • Geographical Trends: North America is leading the stem cell manufacturing market due to several factors, including the presence of leading biotechnology and pharmaceutical companies, a supportive regulatory framework towards clinical trials and commercialization of stem cell manufacturing, robust research and development (R&D) infrastructure, and the rising demand for regenerative medicine therapies in the region.
  • Competitive Landscape: Some of the major market players in the stem cell manufacturing industry include Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc., among many others.
  • Challenges and Opportunities: Government initiatives to boost the biotechnology and biopharmaceutical industries represent a significant opportunity for the market. Initiatives, such as grants, tax incentives, and subsidies, aim to promote R&D, attract investments, adopt advanced technologies, and accelerate scientific discoveries and innovations in therapies and treatments. However, the market also faces a significant challenge like technical limitations associated with manufacturing scale-up, which will require companies specialized equipment and infrastructure to overcome.

Stem Cell Manufacturing Market Trends:

Increasing Investments in Stem Cell Research and Regenerative Medicine

The global stem cell manufacturing market is experiencing a significant upsurge due to the substantial investments pouring into stem cell research and regenerative medicine. Governments and private organizations are channeling resources toward these fields, recognizing their potential to revolutionize healthcare. This driver is fueled by the promising prospects of stem cell therapies in addressing previously untreatable conditions, such as neurodegenerative diseases and spinal cord injuries. For instance, an article published in the New England Journal of Medicine in August 2023 revealed the anticipated potential of stem cell gene therapy in treating Sickle Cell Disease (SCD). These investments support cutting-edge research, the development of advanced manufacturing techniques, and the expansion of clinical trials. For example, in September 2021, LifeCell International Pvt. Ltd received an investment of INR 225 crore (USD 27.2 million) from OrbiMed Asia Partners IV to further leverage its technological expertise and wide network to foray into adjacent new categories like fertility health and cell-based therapeutics. Moreover, in November 2023, ACROBiosystems Inc., a US-based company specializing in recombinant proteins and essential reagents, launched GM-grade DLL4 protein, a soluble form of Delta-like Ligand 4 (DLL4), crucial in stem cell development and differentiation.

Rising Prevalence of Chronic Diseases and the Demand for Innovative Treatments

Another vital driver propelling the global stem cell manufacturing market is the escalating prevalence of chronic diseases. Conditions like diabetes, heart disease, and autoimmune disorders are on the rise, necessitating novel and effective treatments. Stem cell therapies hold immense promise in addressing these ailments by regenerating damaged tissues and organs. For instance, in March 2021, Vertex Pharmaceuticals received FDA grant as a fast track designation to VX-880, a human stem-cell derived therapy for patients with Type-1 diabetes. Moreover, as per the December 2022 data provided by the US Food and Drug Administration (FDA), there are over 7,000 rare diseases that affect more than 30 million people in the United States. The prevalence of chronic diseases rises with age, and stem cell manufacturing exhibits promise in combating these conditions. For example, a World Health Organization factsheet from October 2021 projects that globally there will be 1.4 billion people over the age of 65 by 2030 and this number is expected to double at 2.2 billion by 2050.

Advancements in Biotechnology and Cell Culture Techniques

Advancements in biotechnology and cell culture techniques are revolutionizing the field of stem cell manufacturing. This driver is pivotal in enhancing the efficiency and scalability of stem cell production. Breakthroughs in cell culture technology, such as 3D cell culture systems and bioreactors, enable the cultivation of high-quality stem cells in larger quantities. Additionally, innovations in genetic editing techniques, like CRISPR-Cas9, offer precise control over stem cell characteristics, further expanding their therapeutic potential. These advancements not only streamline the manufacturing process but also ensure the safety and quality of stem cell-based therapies, instilling confidence among healthcare professionals and patients alike. For instance, in September 2021, Cellino, a US-based biotech company with specialization in stem cell manufacturing, presented how its system integrates AI, machine learning, and lasers, along with other hardware and software, to enhance yields and reduce production costs.

Stem Cell Manufacturing Market Segmentation:

Breakup by Product:

  • Consumables
    • Culture Media
    • Others
  • Instruments
    • Bioreactors and Incubators
    • Cell Sorters
    • Others
  • Stem Cell Lines
    • Hematopoietic Stem Cells (HSC)
    • Mesenchymal Stem Cells (MSC)
    • Induced Pluripotent Stem Cells (iPSC)
    • Embryonic Stem Cells (ESC)
    • Neural Stem Cells (NSC)
    • Multipotent Adult Progenitor Stem Cells

Consumables dominate the market

The consumables segment within the stem cell manufacturing market is experiencing robust growth due to the increasing adoption of stem cell-based research and therapies, necessitating a constant supply of consumables, including cell culture media, reagents, and growth factors. As research in this field expands, so does the demand for these essential materials. Moreover, the growing number of stem cell clinical trials and applications in regenerative medicine fuels the consumption of consumables. Clinical research and therapy development require a consistent and reliable source of high-quality consumables to ensure the safety and efficacy of stem cell-based treatments. In line with this, technological advancements in the production of consumables are driving growth.

Breakup by Application:

  • Research Applications
    • Life Science Research
    • Drug Discovery and Development
  • Clinical Application
    • Allogenic Stem Cell Therapy
    • Autologous Stem Cell Therapy
  • Cell and Tissue Banking Applications

Research applications dominate the market

The growth of the research applications segment within the stem cell manufacturing market is underpinned by the relentless pursuit of scientific knowledge and breakthrough discoveries in stem cell biology. Stem cells serve as essential tools for investigating various biological processes, disease mechanisms, and potential therapeutic avenues. Researchers across diverse fields, including regenerative medicine, developmental biology, and drug development, rely on stem cells to advance their studies. Moreover, the increasing funding and grants allocated to stem cell research bolster this segment's growth. Governments, private institutions, and non-profit organizations recognize the transformative potential of stem cell research and provide financial support to drive innovation. Additionally, technological advancements in stem cell culture techniques, genetic editing, and cell characterization tools enhance the efficiency and accuracy of research applications. These advancements enable researchers to work with a broader range of stem cell types and manipulate them with precision, further expanding the scope of research possibilities. For instance, in May 2023, Sernova announced research collaboration with AstraZeneca to evaluate novel potential therapeutic cell applications.

Breakup by End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes, Research Laboratories and Contract Research Organizations
  • Hospitals and Surgical Centers
  • Cell and Tissue banks
  • Others

Pharmaceutical & biotechnology companies dominate the market

The growth of pharmaceutical and biotechnology companies is propelled by the continuous expansion of the global population and the aging demographic trends. With an aging population, the demand for healthcare services, medications, and innovative therapies rises, providing a substantial market for pharmaceutical and biotechnology companies to cater to. Moreover, the increasing prevalence of chronic diseases, including cardiovascular disorders, cancer, and diabetes, necessitates ongoing research and the development of new pharmaceutical solutions. These companies play a pivotal role in creating advanced drugs and therapies to combat these health challenges. Furthermore, advancements in biotechnology, including gene therapy, precision medicine, and biopharmaceuticals, are shaping the industry.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest stem cell manufacturing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American region is experiencing robust growth in the stem cell manufacturing market, propelled by the substantial government funding and private investments in stem cell research and regenerative medicine. These financial commitments support cutting-edge research, clinical trials, and the development of advanced manufacturing techniques. Moreover, the prevalence of chronic diseases, such as diabetes, heart disease, and neurodegenerative disorders, is on the rise in North America. Stem cell therapies offer innovative solutions to address these conditions, fueling demand for their production. In line with this, the region boasts a highly developed biotechnology sector, leading to significant advancements in cell culture techniques and bioprocessing technologies. This ensures efficient and scalable stem cell production, strengthening the industry's foothold in North America. Furthermore, regulatory frameworks in North America provide a conducive environment for stem cell research and clinical trials, fostering growth and innovation. Collaborative efforts between academic institutions and industry players, along with growing public awareness of the potential of stem cell-based treatments, are additional drivers.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the Stem Cell Manufacturing industry include Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc., among many others.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The competitive landscape within the global stem cell manufacturing market is characterized by a dynamic interplay of numerous players, each vying to establish their prominence and contribute to the industry's growth. These entities span a spectrum of organizations, including research institutions, biotechnology companies, pharmaceutical giants, and contract manufacturing organizations. Their diverse backgrounds and resources contribute to a multifaceted ecosystem that fosters innovation and advancements in stem cell manufacturing. Key competitive strategies encompass research and development efforts to enhance manufacturing processes, scale up production, and improve the quality and safety of stem cell-based therapies. Additionally, partnerships and collaborations between these players are common, facilitating knowledge sharing and the development of cutting-edge technologies. For instance, in June 2021, Catalent, in a strategic move, acquired RheinCell Therapeutics Gmbh for an undisclosed amount to expand the creation of advanced cell treatments, thereby enhancing Catalent's capacity for large-scale production. Regulatory compliance and adherence to ethical standards are pivotal in maintaining credibility within the market. Moreover, market participants often engage in marketing and educational initiatives to increase awareness of stem cell therapies among healthcare professionals and the public, further expanding their reach.

Key Questions Answered in This Report

  • 1.What was the size of the global stem cell manufacturing market in 2024?
  • 2.What is the expected growth rate of the global stem cell manufacturing market during 2025-2033?
  • 3.What are the key factors driving the global stem cell manufacturing market?
  • 4.What has been the impact of COVID-19 on the global stem cell manufacturing market?
  • 5.What is the breakup of the global stem cell manufacturing market based on product?
  • 6.What is the breakup of the global stem cell manufacturing market based on the application?
  • 7.What is the breakup of the global stem cell manufacturing market based on the end user?
  • 8.What are the key regions in the global stem cell manufacturing market?
  • 9.Who are the key players/companies in the global stem cell manufacturing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Stem Cell Manufacturing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Culture Media
      • 6.1.2.2 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bioreactors and Incubators
      • 6.2.2.2 Cell Sorters
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Stem Cell Lines
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hematopoietic Stem Cells (HSC)
      • 6.3.2.2 Mesenchymal Stem Cells (MSC)
      • 6.3.2.3 Induced Pluripotent Stem Cells (iPSC)
      • 6.3.2.4 Embryonic Stem Cells (ESC)
      • 6.3.2.5 Neural Stem Cells (NSC)
      • 6.3.2.6 Multipotent Adult Progenitor Stem Cells
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Research Applications
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Life Science Research
      • 7.1.2.2 Drug Discovery and Development
    • 7.1.3 Market Forecast
  • 7.2 Clinical Application
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Allogenic Stem Cell Therapy
      • 7.2.2.2 Autologous Stem Cell Therapy
    • 7.2.3 Market Forecast
  • 7.3 Cell and Tissue Banking Applications
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical & Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic Institutes, Research Laboratories and Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hospitals and Surgical Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cell and Tissue banks
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Anterogen Co. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Techne Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Corning Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 FUJIFILM Holdings Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Lonza Group AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Sartorius AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Takara Bio Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis